Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-20

FDA Approved: VALSARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VALSARTAN submitted by Unichem Pharmaceuticals (USA), Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)